ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 1 filers reported holding ASSERTIO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $168,000 | -85.6% | 258,824 | -72.2% | 0.02% | -25.0% |
Q4 2019 | $1,163,000 | -12.4% | 930,134 | -10.3% | 0.03% | 0.0% |
Q3 2019 | $1,327,000 | -66.3% | 1,036,375 | -9.2% | 0.03% | -62.4% |
Q2 2019 | $3,938,000 | +3.4% | 1,141,332 | +52.0% | 0.08% | +2.4% |
Q1 2019 | $3,807,000 | +53.0% | 750,879 | +9.0% | 0.08% | +27.7% |
Q4 2018 | $2,488,000 | +31.8% | 689,070 | +117.7% | 0.06% | +66.7% |
Q3 2018 | $1,887,000 | – | 316,544 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 3,600,316 | $4,500,000 | 0.51% |
Aristides Capital LLC | 140,625 | $176,000 | 0.14% |
TSP Capital Management Group, LLC | 248,100 | $310,000 | 0.13% |
Anson Funds Management LP | 86,767 | $108,000 | 0.12% |
Factorial Partners, LLC | 97,000 | $122,360,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 267,309 | $334,000 | 0.04% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,113,351 | $1,392,000,000 | 0.04% |
DELTEC ASSET MANAGEMENT LLC | 145,700 | $182,000 | 0.04% |
OAKTREE CAPITAL MANAGEMENT LP | 1,492,455 | $1,865,000 | 0.04% |
OXFORD ASSET MANAGEMENT LLP | 930,134 | $1,163,000 | 0.03% |